Lung Cancer Trials Ask AI to find trials
CompletedNot applicableNCT03683940
Official study title

Pilot Study of High Risk Lung Cancer Screening

Study summary

This study is a prospective trial of 200 individuals at high risk for lung cancer who are not eligible for lung cancer screening under current screening guidelines.

Ask AI to explain this study
Start here

Key things to know

Main goalScreening

This describes the study’s primary purpose.

What is being studiedScreening

The study team can explain what participation involves.

Who it may be forLung Cancer

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Dec 12, 2023 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?University of Colorado, Denver

Study sponsor

01
Study overview

What this study is about

Purpose
Screening
Study type
Interventional
Phase
Not applicable
Sponsor
University of Colorado, Denver
Interventions being studied
Diagnostic Test: Screening
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

1. Adult 40-82 yrs of age. 2. Presenting for lung cancer screening evaluation. 3. Calculated 6 yr lung cancer risk \>1.5% for patients 40-77 years of age or \>4% for patients 78-82 years of age. 4. Able and willing to provide informed consent.

Reasons someone may not be able to joinExclusion criteria

1. Eligible for clinically indicated lung cancer screening (55-80 yr old, \>30 pky smoking history, still smoking or quit smoking within the last 15 yr). 2. Chest CT performed within the last year. 3. Life expectancy less than 6 months. 4. Symptoms clinically consistent with lung cancer. 5. Unable or unwilling to undergo treatment for lung cancer. 6. Any individual who does not give oral and written consent for participation.

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • University of Colorado HospitalDenver, Colorado

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Dec 12, 2023. Always confirm current availability with the study team.

View original record ↗